Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) have earned an average rating of “Buy” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) have earned an average rating of “Buy” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
